This inventor holds 23 USPTO granted patents and 7 published patent applications and 12 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Boehringer Ingelheim International Gmbh, Bayer Pharmaceuticals Corporation, Bayer Healthcare LLC. Active years: 2004-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
12 out of 1,562 
7 out of 71 
4 out of 789 Years Active: 2004-2019
Areas of Expertise:
Title: Innovations by Robert Sibley: A Pioneer in Modulation of ROR Gamma
Introduction
Robert Sibley, an innovative inventor based in North Haven, CT, has made significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of 23 patents, Sibley has focused his research on compounds that act as modulators of ROR gamma, a receptor implicated in various diseases.
Latest Patents
Among Robert Sibley's latest patents are notable inventions contributing to the modulation of ROR gamma. The present inventions encompass compounds of formula (I), wherein the variables are defined to suit the modulation of ROR gamma, aiding in the treatment of related diseases. Additionally, these patents detail processes for synthesizing compounds of formula (I) and include pharmaceutical preparations that utilize these innovative compounds.
Career Highlights
Sibley's career spans prominent institutions where he has leveraged his expertise in pharmaceuticals. He has worked extensively at Boehringer Ingelheim International GmbH and Bayer Pharmaceuticals Corporation. His dedication and pioneering approach have solidified his reputation as a key figure in drug development and therapeutic innovation.
Collaborations
Throughout his career, Robert Sibley have collaborated with esteemed colleagues including Jacques P. Dumas and Uday R. Khire. These partnerships have contributed to the advancement of research in the modulation of ROR gamma, highlighting the importance of teamwork in driving scientific discovery.
Conclusion
Robert Sibley's work in the modulation of ROR gamma exemplifies the impact of innovation in the pharmaceutical industry. His 23 patents reflect a commitment to advancing healthcare solutions, proving that meticulous research and collaboration can lead to groundbreaking developments in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile